Soundbites® is the registered trademark for ACEMg. ACEMg patents are owned by the University of Michigan and exclusively licensed to Soundbites Public Benefit Corporation, Ann Arbor, MI, USA. 


ACEMg is covered by U.S. Patents for preventing and treating temporary and permanent tinnitus (9,770,433); treating noise-induced hearing loss (7,951,845, 8,927,528, 8,338,398 and 9,889,156); age-related hearing loss (9,919,008); the hearing loss side effects of aminoglycoside antibiotics (8,338,397); hearing loss caused by certain genetic mutations (9,144,565); and hearing loss from congenital cytomegalovirus (10,238,59).